| Folic acid-conjugated radioluminescent calcium tungstate nanoparticles as radio-sensitizers for cancer radiotherapy VJ Pizzuti, R Misra, J Lee, SE Torregrosa-Allen, MP Currie, SR Clark, ... ACS Biomaterials Science & Engineering 5 (9), 4776-4789, 2019 | 17 | 2019 |
| Targets for chimeric antigen receptor T-cell therapy of acute myeloid leukemia C Schorr, F Perna Frontiers in Immunology 13, 1085978, 2022 | 14 | 2022 |
| Comparative analysis of three studies measuring fluorescence from engineered bacterial genetic constructs J Beal, GS Baldwin, NG Farny, M Gershater, T Haddock-Angelli, ... PloS one 16 (6), e0252263, 2021 | 12 | 2021 |
| Thrombotic Events Are Unusual Toxicities of Chimeric Antigen Receptor T-Cell Therapies C Schorr, J Forindez, M Espinoza-Gutarra, R Mehta, N Grover, F Perna International Journal of Molecular Sciences 24 (9), 8349, 2023 | 3 | 2023 |
| Pilot-Scale Optimization of the Solvent Exchange Production and Lyophilization Processing of PEG–PLA Block Copolymer-Encapsulated CaWO4 Radioluminescent Nanoparticles for … AP Patel, CR Schorr, D Viswanath, K Sarkar, NJ Streb, VJ Pizzuti, R Misra, ... Industrial & Engineering Chemistry Research 60 (19), 7081-7096, 2021 | 2 | 2021 |
| Tailoring CAR T cell technology for T cell leukemia C Schorr, F Perna Molecular Therapy 31 (3), 603-604, 2023 | 1 | 2023 |
| A Place to Heal C Schorr Insight: Indiana University Medical Student Research Journal 5 (1), 23-23, 2023 | | 2023 |
| Deficits in our understanding of natural killer cell development in mouse and human C Schorr, MS Krishnan, M Capitano Current Opinion in Hematology 30 (4), 106-116, 2023 | | 2023 |
| Emerging Thrombotic Complications in Patients Undergoing Chimeric Antigen Receptor T Cell Therapies MR Espinoza-Gutarra, C Schorr, M Krishnan, MI Abu Zaid, RP Mehta, ... Blood 140 (Supplement 1), 8530-8531, 2022 | | 2022 |
